NovoCure Ltd. (NVCR) PT Lowered to $40 at Wells Fargo
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $17.53 +3.42%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Wells Fargo analyst Larry Biegelsen lowered the price target on NovoCure Ltd. (NASDAQ: NVCR) to $40.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Citi Upgrades Insurance Australia Group Ltd. (IAG:AU) (IAUGD) to Buy
- Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,600 at Citi
- Citi Downgrades M3, Inc (2413:JP) (MTHRF) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
